Michael J. Fox Foundation and Medtronic Partner to Help More People with Parkinson's Understand Deep Brain Stimulation
Key Highlights
- ➤Medtronic and MJFF launch DBS education initiative for Parkinson’s patients and caregivers
- ➤Medtronic supported DBS therapy for more than 30 years and served over 200,000 people globally
- ➤Medtronic introduced the world’s first FDA-approved adaptive DBS system in 2025
- ➤MJFF has funded more than $29 million in Parkinson’s DBS research since 2000
Expert Statements
Sohini Chowdhury, Chief program officer of The Michael J. Fox Foundation
“Our urgent mission is to accelerate a cure for Parkinson's by advancing the most promising research. Partnerships with industry help us do more for people and families by expanding access to clear, practical resources that support informed decisions and meaningful participation in our mission.”
Sohini Chowdhury, Chief program officer of The Michael J. Fox Foundation
“Together with Medtronic, we're creating robust educational materials to help people explore what DBS may offer and to keep them updated on the latest scientific progress.”
Andrea Swain, President of Neuromodulation, part of the Medtronic Neuroscience portfolio
“Innovation can only make a difference if people know it exists.”
Andrea Swain, President of Neuromodulation, part of the Medtronic Neuroscience portfolio
“Our responsibility extends beyond pioneering breakthrough technologies to helping more people understand the therapies available to them. By combining Medtronic's decades of DBS expertise and The Michael J. Fox Foundation's trusted connection to the Parkinson's community, we can help close a critical gap in therapy awareness.”
John L. Lipp, Writer, research advocate and participant in the ADAPT-PD multi-center clinical trial
“Living with Parkinson's has reminded me that no two days are alike. My experience with DBS the past five years has been meaningful; it's helped me stay connected to things I love, like being active with my family and friends.”
John L. Lipp, Writer, research advocate and participant in the ADAPT-PD multi-center clinical trial
“I know firsthand what technology like this can mean for someone living with Parkinson's. But deciding whether DBS is right for you is a personal choice. People need clear information to understand what it may mean for them, weigh their options, and talk with their care team. I hope this initiative helps patients and families feel more prepared to have those conversations.”
Michael J. Fox Foundation and Medtronic Partner to Help More People with Parkinson's Understand Deep Brain Stimulation PR Newswire
* New education initiative aims to expand awareness of DBS and empower people with Parkinson's to make informed decisions about their treatment options NEW YORK and GALWAY, Ireland, Nov. 4, 2026 /PRNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) and Medtronic plc (NYSE: MDT) today announce a new educational initiative to help people with Parkinson's disease (PD) and their caregivers better understand deep brain stimulation (DBS), an established treatment option for managing certain symptoms of the disease.
Get started
Create a free account to read the full story.